Foresite Capital Management IV, LLC Buys Alector Inc, Aerie Pharmaceuticals Inc, Voyager Therapeutics Inc, Sells Immunomedics Inc, MyoKardia Inc, Arbutus Biopharma Corp

• New Purchases: ALEC, MDCO, VCYT,
• Added Positions: AERI, VYGR, CYTK, RYTM, INSM, OPTN,
• Reduced Positions: IMMU, MYOK, BHVN, CBAY, ABUS,

For the details of Foresite Capital Management IV, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/foresite+capital+management+iv%2C+llc/current-portfolio/portfolioportfolio

1. Insmed Inc (INSM) - 1,561,185 shares, 14.90% of the total portfolio. Shares added by 1.78%
2. Ascendis Pharma A/S (ASND) - 245,424 shares, 10.54% of the total portfolio.
3. Alector Inc (ALEC) - 1,143,462 shares, 8.10% of the total portfolio. New Position
4. Cytokinetics Inc (CYTK) - 1,898,970 shares, 7.96% of the total portfolio. Shares added by 10.20%
5. Biohaven Pharmaceutical Holding Co Ltd (BHVN) - 429,690 shares, 7.02% of the total portfolio. Shares reduced by 17.14%

Foresite Capital Management IV, LLC initiated holding in Alector Inc. The purchase prices were between $16.26 and $26.42, with an estimated average price of $20.32. The stock is now traded at around $17.80. The impact to a portfolio due to this purchase was 8.1%. The holding were 1,143,462 shares as of .

Foresite Capital Management IV, LLC initiated holding in The Medicines Co. The purchase prices were between $27.53 and $37.25, with an estimated average price of $32.61. The stock is now traded at around $32.58. The impact to a portfolio due to this purchase was 3.39%. The holding were 249,672 shares as of .

Foresite Capital Management IV, LLC initiated holding in Veracyte Inc. The purchase prices were between $22.1 and $28.56, with an estimated average price of $24.94. The stock is now traded at around $26.95. The impact to a portfolio due to this purchase was 2.13%. The holding were 200,000 shares as of .

Foresite Capital Management IV, LLC added to a holding in Aerie Pharmaceuticals Inc by 183.26%. The purchase prices were between $28.97 and $48.21, with an estimated average price of $38.56. The stock is now traded at around $24.38. The impact to a portfolio due to this purchase was 4.28%. The holding were 600,000 shares as of .

Foresite Capital Management IV, LLC added to a holding in Voyager Therapeutics Inc by 201.89%. The purchase prices were between $19.18 and $27.88, with an estimated average price of $22.85. The stock is now traded at around $20.56. The impact to a portfolio due to this purchase was 3.64%. The holding were 536,771 shares as of .